Center of Integrated Biomedical and Bioengineering Research

Center of Integrated Biomedical and Bioengineering Research

CIBBR
 
National Institutes of Health Phase 2 - $10M award will accelerate innovative human health research at UNH.
Committed to the idea that truly valuable, paradigm-shifting research is often conducted in the space between research disciplines and across academic units and establishing UNH as a Center of Biomedical Research Excellence (COBRE):
  • Increasing the number of NIH-funded research project grants awarded to UNH faculty
  • Accelerating hiring and advancement of biomedical and bioengineering researchers
  • Acquiring state-of-the-art instrumentation in well-managed core facilities
  • Encouraging clinical research, commercial opportunities, and translational medicine
Two students work in a lab using advanced instrumentation.

UNH's Center of Integrated Biomedical and Bioengineering Research Receives $10M NIH Grant

UNH's Center of Integrated Biomedical and Bioengineering Research Receives $10M NIH Grant

National Institutes of Health Phase 2 award will accelerate innovative human health research at UNH...

Article

CIBBR NEWS

Researcher in full PPE works beneath a hood

Sequencing Variants

Sequencing Variants

With NIH grant, UNH will help understand COVID-19 variants...

Article
A photo of Marie Carlota Dao (center) with research students Brandy Moser (left) and Jason Hansen.

Dedicated to Health Disparities Research

Dedicated to Health Disparities Research

Nutrition researcher named a faculty fellow in a National Heart, Lung, and Blood Institute funded...

Article
Researcher Harish Vashisth stands with arms crossed in darkened hallway

Repurposing Drug Compound Could Slow COVID Spread

Repurposing Drug Compound Could Slow COVID Spread

Acts to inhibit “molecular scissors” that lets virus replicate...

Article

Funded by a five-year, $10 million National Institutes of Health (NIH) grant, the UNH CIBBR strives to bridge the gap between basic biomedical and bioengineering research and clinical and/or commercial outcomes.  This COBRE is supported by the National Institute of General Medical Sciences, under Award Number P20GM113131.